We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
Cap. Flow
-$324M
Cap. Flow %
-7.96%
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$31.9M
2
MCK icon
McKesson
MCK
+$27.5M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
SBUX icon
Starbucks
SBUX
+$27M
5
NVDA icon
NVIDIA
NVDA
+$21M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$109M
2
IYR icon
iShares US Real Estate ETF
IYR
+$31.3M
3
EMC
EMC CORPORATION
EMC
+$24.7M
4
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
+$23.8M
5
K
Kellanova
K
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 28.72%
2 Financials 13.85%
3 Technology 10.05%
4 Consumer Discretionary 8.55%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$114M 2.8%
1,161,790
+82,817
+8% +$9.2M
AMGN icon
2
Amgen
AMGN
$198B
$107M 2.64%
776,974
-94,675
-11% -$14.9M
JNJ icon
3
Johnson & Johnson
JNJ
$603B
$96M 2.36%
1,028,471
+47,086
+5% +$4.55M
AAPL icon
4
Apple
AAPL
$4.81T
$71.8M 1.76%
2,602,668
-200,120
-7% -$5.87M
CELG
5
DELISTED
Celgene Corp
CELG
$70.2M 1.72%
648,730
+41,548
+7% +$5.16M
PEP icon
6
PepsiCo
PEP
$184B
$62.6M 1.54%
663,607
+215,465
+48% +$20.5M
BIIB icon
7
Biogen
BIIB
$30B
$62.1M 1.52%
212,736
+9,530
+5% +$3.15M
NKE icon
8
Nike
NKE
$63.7B
$53.4M 1.31%
868,988
+564,100
+185% +$31.9M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.8B
$50.2M 1.23%
107,868
-14,485
-12% -$7.78M
SBUX icon
10
Starbucks
SBUX
$119B
$46.6M 1.14%
819,862
+481,108
+142% +$27M
V icon
11
Visa
V
$677B
$45M 1.1%
645,279
-41,197
-6% -$2.94M
PFE icon
12
Pfizer
PFE
$142B
$44.7M 1.1%
1,499,810
-86,368
-5% -$2.77M
PG icon
13
Procter & Gamble
PG
$345B
$44.2M 1.09%
614,496
+361,187
+143% +$27.1M
XOM icon
14
ExxonMobil
XOM
$629B
$40.3M 0.99%
541,596
-70,836
-12% -$5.46M
T icon
15
AT&T
T
$155B
$36.1M 0.89%
1,467,500
+103,783
+8% +$2.65M
MRK icon
16
Merck
MRK
$312B
$35.4M 0.87%
751,303
-83,321
-10% -$4.43M
QCOM icon
17
Qualcomm
QCOM
$183B
$34.5M 0.85%
641,779
-339,254
-35% -$20.2M
VZ icon
18
Verizon
VZ
$183B
$34M 0.84%
781,605
-90,508
-10% -$4.18M
INCY icon
19
Incyte
INCY
$23.5B
$32.8M 0.81%
297,384
+34,212
+13% +$3.84M
MSFT icon
20
Microsoft
MSFT
$2.95T
$31M 0.76%
699,657
-308,612
-31% -$13.9M
ABBV icon
21
AbbVie
ABBV
$452B
$30.7M 0.75%
563,563
+27,428
+5% +$1.79M
KO icon
22
Coca-Cola
KO
$353B
$30.5M 0.75%
761,286
-38,390
-5% -$1.54M
MCK icon
23
McKesson
MCK
$97B
$27.7M 0.68%
149,655
+129,737
+651% +$27.5M
TRV icon
24
Travelers Companies
TRV
$81.6B
$27.6M 0.68%
276,986
-24,302
-8% -$2.49M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$122B
$27.4M 0.67%
262,845
-1,009
-0.4% -$130K
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2015 Portfolio in Review

As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.

  • Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
  • Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
  • Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
  • Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
  • Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
  • Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.